Our mission is to lower drug development barriers through accessible digital biology tools and rapid testing with cost-effective organoid models to advance biomedical discovery
Something big is coming
We are about to put the power of digital biology in everyone's hands and give them the ability to rapidly test their designs in clinically relevant organoid models. Be the first to know.
Sign up for the announcement
Our Services
A complete design-test cycle for accelerating biomedical discovery
Design → Test → Refine → Repeat
Digital Biology
We replace tenuous GitHub installs, command-line interactions, and complex coding with a simple interaction point which may even be called agentic. Our digital biology platform enables you to design small molecule and protein-based therapies with unprecedented ease and accuracy.
Key Features:
- User-friendly interface for designing small molecule and protein therapies
- No coding experience required to leverage advanced computational models
- AI-assisted molecule design and protein engineering tools
- Seamless integration with our organoid testing platform for immediate validation
- From in silico therapeutic design directly to real-world efficacy testing
Organoid Models
Say goodbye to working with kits and protocols that don't work the way you want and endless optimization cycles. We provide the most beautiful organoids ready for your experiments at cost-effective pricing that lowers barriers to access. Our morphologically diverse stem cell-derived organoids include kidney, liver, cardiac, CNS, and intestine models.
Key Features:
- Ready-to-use, fully characterized organoids for immediate testing
- Cost-effective pricing to democratize access to advanced biological tools
- Multiple tissue types available: kidney, liver, cardiac, CNS, and intestine
- Choose from our list of disease models or request bespoke development
- Results validate and refine your therapeutic designs from Digital Biology
Which disease do you want to test your new digital design therapy in?
Pick from our list of established organoid models or ask us to develop a bespoke disease model for your therapeutic candidate.
Our Technology Platform
Our integrated automation platform enables large-scale production of stem cell-derived organoids. From stem cell passage to terminally differentiated organoids, our system combines advanced cell culture methods to create consistent, high-quality organoid models at scale.
We're constantly innovating on this platform to drive down costs while increasing output, making advanced biological models accessible to more researchers. Each organoid contains all the right cell types to accurately represent the organ of interest, providing the most physiologically relevant testing environment.
Automated Production Platform
End-to-end automation system for high-throughput organoid production, from stem cell passage to terminally differentiated organoids.
Complete Cellular Composition
Each organoid model contains all the right cell types to accurately represent the organ of interest for physiologically relevant testing.
Scalable Manufacturing
Continuous innovation in our production platform to drive down costs while increasing output and maintaining consistent quality.
Integrated Quality Control
Automated monitoring and quality control systems ensure every organoid meets our stringent standards for research and testing.
Get in touch
Find out how we can accelerate your drug development program with our validated organoid platform.